Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TAZ and YAP are frequently activated oncoproteins in sarcomas.
Fullenkamp CA, Hall SL, Jaber OI, Pakalniskis BL, Savage EC, Savage JM, Ofori-Amanfo GK, Lambertz AM, Ivins SD, Stipp CS, Miller BJ, Milhem MM, Tanas MR. Fullenkamp CA, et al. Among authors: tanas mr. Oncotarget. 2016 May 24;7(21):30094-108. doi: 10.18632/oncotarget.8979. Oncotarget. 2016. PMID: 27129148 Free PMC article.
A comprehensive evaluation of Hippo pathway silencing in sarcomas.
Merritt NM, Fullenkamp CA, Hall SL, Qian Q, Desai C, Thomason J, Lambertz AM, Dupuy AJ, Darbro B, Tanas MR. Merritt NM, et al. Among authors: tanas mr. Oncotarget. 2018 Aug 3;9(60):31620-31636. doi: 10.18632/oncotarget.25824. eCollection 2018 Aug 3. Oncotarget. 2018. PMID: 30167083 Free PMC article.
Combination therapies for MPNSTs targeting RABL6A-RB1 signaling.
Kohlmeyer JL, Gordon DJ, Tanas MR, Dodd RD, Monga V, Darbro BW, Quelle DE. Kohlmeyer JL, et al. Among authors: tanas mr. Oncotarget. 2021 Jan 5;12(1):10-14. doi: 10.18632/oncotarget.27862. eCollection 2021 Jan 5. Oncotarget. 2021. PMID: 33456709 Free PMC article.
Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas.
Desai C, Thomason J, Kohlmeyer JL, Reisetter AC, Ahirwar P, Jahanseir K, Leidinger M, Ofori-Amanfo G, Fritchie K, Velu SE, Breheny P, Quelle DE, Tanas MR. Desai C, et al. Among authors: tanas mr. Oncotarget. 2021 Apr 13;12(8):740-755. doi: 10.18632/oncotarget.27928. eCollection 2021 Apr 13. Oncotarget. 2021. PMID: 33889298 Free PMC article.
40 results